WHO ICTRP trial

To explore the curative effect of Corbrin Capsule and influencing factors of…

ChiCTR1800014662 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting

Key facts

Trial ID ChiCTR1800014662
Public title To explore the curative effect of Corbrin Capsule and influencing factors of proteinuria caused by Apatinib: A prospective randomized controlled study
Scientific title To explore the curative effect of Corbrin Capsule and influencing factors of proteinuria caused by Apatinib: A prospective randomized controlled study
Primary sponsor Nanyang Central Hospital, He'nan
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Recruiting
Study type Interventional study
Phase Other
Countries China
Conditions cancer
Interventions research group:Oral Bailing Capsule;observation group:observation
Registration date Jan 27, 2018
Target size research group:60;observation group:60
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations